New cell therapy approach shows promise for long-term treatment of Type 1 diabetes mellitus

A team from the University of Tokyo (Japan) has developed a novel graft method for the delivery of pancreatic beta cells via cell therapy. The graft was tested in mice. The results of their study, published in iScience, demonstrated that their approach could be used for the long-term treatment of Type 1 diabetes mellitus. “Cell therapy is an exciting, but challenging, approach to treat Type 1 diabetes mellitus,” explained lead author of the study, Shoji Takeuchi (University of Tokyo). “The challenge arises from the difficulty to make large amounts of human beta cells in a dish, and more importantly, to...